Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADA-SWITCH: Adalimumab Biosimilar vs Original in IBD
NCT04131322Phase 4Terminated
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Oct 2019
- Primary completion
- Jun 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, ulcerative colitis (UC), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Oct 2019; status: terminated.
02
Drugs
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04131322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04131322.